Showing results (31-40 of 148) with videos related to
Sort By:
Pageof 15
Haematologica|March 31, 2022
TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemiaNaomi Thielemans, Sofie Demeyer, Nicole Mentens, et al.Heliyon|October 18, 2021
Preference and perception of value chain actors to quality parameters and factors affecting the quality of tef (Eragrostis tef (Zucc. Trotter) in Central and Northwestern EthiopiaAbewa Anteneh, Adgo Enyew, Alemayehu Getachew, et al.Current Opinion in Hematology|December 17, 2003
The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemiaJan Cools, Elizabeth H Stover, Iwona Wlodarska, et al.Haematologica|January 19, 2007
The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitorsEls Lierman, Idoya Lahortiga, Helen Van Miegroet, et al.Blood|September 11, 2007
Uniform sensitivity of FLT3 activation loop mutants to the tyrosine kinase inhibitor midostaurinElly V Barry, Jennifer J Clark, Jan Cools, et al.Haematologica|June 8, 2006
Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13)Hilde Janssen, Iwona Wlodarska, Cristina Mecucci, et al.Acta Oncologica (Stockholm, Sweden)|September 18, 2013
FLT1 kinase is a mediator of radioresistance and survival in head and neck squamous cell carcinomaEvert Jan Van Limbergen, Piotr Zabrocki, Michaël Porcu, et al.Haematologica|August 1, 2009
The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradationFederica Toffalini, Anders Kallin, Peter Vandenberghe, et al.Blood|April 9, 2004
The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and managementJason Gotlib, Jan Cools, James M Malone, et al.Haematologica|July 28, 2011
Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphomaMaria Kleppe, Thomas Tousseyn, Eva Geissinger, et al.Pageof 15